Evaluating guidelines on continuation of anti-tumour necrosi…
Evaluating guidelines on continuation of anti-tumour necrosis factor treatment after 3 months%253A clinical effectiveness and costs of observed care and different alternative strategies.
Article, Chapter
Full text availability for this item
Collection:
BMJ Journals All Titles
Opens in new Window
Coverage:
- 1939~present; volume:1~present;issue:1~present